180 related articles for article (PubMed ID: 28584849)
21. Cost Drivers of a Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Phase 3 Clinical Trial.
Stergiopoulos S; Calvert SB; Brown CA; Awatin J; Tenaerts P; Holland TL; DiMasi JA; Getz KA
Clin Infect Dis; 2018 Jan; 66(1):72-80. PubMed ID: 29020279
[TBL] [Abstract][Full Text] [Related]
22. Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia.
Tamma PD; Goodman KE; Harris AD; Tekle T; Roberts A; Taiwo A; Simner PJ
Clin Infect Dis; 2017 Feb; 64(3):257-264. PubMed ID: 28013264
[TBL] [Abstract][Full Text] [Related]
23. Telavancin in the Treatment of Concurrent Staphylococcus aureus Bacteremia: A Retrospective Analysis of ATLAS and ATTAIN Studies.
Wilson SE; Graham DR; Wang W; Bruss JB; Castaneda-Ruiz B
Infect Dis Ther; 2017 Sep; 6(3):413-422. PubMed ID: 28695347
[TBL] [Abstract][Full Text] [Related]
24. Adding double carbapenem therapy to the armamentarium against carbapenem-resistant Enterobacteriaceae bloodstream infections.
White BP; Patel S; Tsui J; Chastain DB
Infect Dis (Lond); 2019 Mar; 51(3):161-167. PubMed ID: 30663923
[TBL] [Abstract][Full Text] [Related]
25. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
Werarak P; Kiratisin P; Thamlikitkul V
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
[TBL] [Abstract][Full Text] [Related]
26. Future Challenges in Pediatric and Neonatal Sepsis: Emerging Pathogens and Antimicrobial Resistance.
Folgori L; Bielicki J
J Pediatr Intensive Care; 2019 Mar; 8(1):17-24. PubMed ID: 31073504
[TBL] [Abstract][Full Text] [Related]
27. Community-onset carbapenem-resistant Klebsiella pneumoniae urinary tract infections in infancy following NICU hospitalisation.
Vergadi E; Bitsori M; Maraki S; Galanakis E
J Pediatr Urol; 2017 Oct; 13(5):495.e1-495.e6. PubMed ID: 28341427
[TBL] [Abstract][Full Text] [Related]
28. Sepsis Care Pathway 2019.
Labib A
Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
[No Abstract] [Full Text] [Related]
29. The role of therapy with aminoglycoside in the outcomes of kidney transplant recipients infected with polymyxin- and carbapenem-resistant Enterobacteriaceae.
Freire MP; de Oliveira Garcia D; Cury AP; Francisco GR; Dos Santos NF; Spadão F; Bueno MFC; Camargo CH; de Paula FJ; Rossi F; Nahas WC; David-Neto E; Pierrotti LC
Eur J Clin Microbiol Infect Dis; 2019 Apr; 38(4):755-765. PubMed ID: 30680569
[TBL] [Abstract][Full Text] [Related]
30. Multicenter Clinical and Molecular Epidemiological Analysis of Bacteremia Due to Carbapenem-Resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States.
Satlin MJ; Chen L; Patel G; Gomez-Simmonds A; Weston G; Kim AC; Seo SK; Rosenthal ME; Sperber SJ; Jenkins SG; Hamula CL; Uhlemann AC; Levi MH; Fries BC; Tang YW; Juretschko S; Rojtman AD; Hong T; Mathema B; Jacobs MR; Walsh TJ; Bonomo RA; Kreiswirth BN
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167547
[TBL] [Abstract][Full Text] [Related]
31. Urinary Tract Infections and Surgical Site Infections due to Carbapenem-Resistant Enterobacteriaceae in Renal Transplant.
Rodrigues Dos Santos BG; Amaral ES; Fernandes PF; Oliveira CM; Rodrigues JL; Perdigão Neto LV; Girão ES
Transplant Proc; 2016; 48(6):2050-5. PubMed ID: 27569943
[TBL] [Abstract][Full Text] [Related]
32. Management of carbapenem-resistant Enterobacteriaceae infections.
Durante-Mangoni E; Andini R; Zampino R
Clin Microbiol Infect; 2019 Aug; 25(8):943-950. PubMed ID: 31004767
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009.
Zilberberg MD; Shorr AF
J Hosp Med; 2013 Oct; 8(10):559-63. PubMed ID: 24022878
[TBL] [Abstract][Full Text] [Related]
34. Cost of hospitalised patients due to complicated urinary tract infections: a retrospective observational study in countries with high prevalence of multidrug-resistant Gram-negative bacteria: the COMBACTE-MAGNET, RESCUING study.
Vallejo-Torres L; Pujol M; Shaw E; Wiegand I; Vigo JM; Stoddart M; Grier S; Gibbs J; Vank C; Cuperus N; van den Heuvel L; Eliakim-Raz N; Carratala J; Vuong C; MacGowan A; Babich T; Leibovici L; Addy I; Morris S;
BMJ Open; 2018 Apr; 8(4):e020251. PubMed ID: 29654026
[TBL] [Abstract][Full Text] [Related]
35. Treatment of sepsis: What is the antibiotic choice in bacteremia due to carbapenem resistant
Alhashem F; Tiren-Verbeet NL; Alp E; Doganay M
World J Clin Cases; 2017 Aug; 5(8):324-332. PubMed ID: 28868304
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013.
Guh AY; Bulens SN; Mu Y; Jacob JT; Reno J; Scott J; Wilson LE; Vaeth E; Lynfield R; Shaw KM; Vagnone PM; Bamberg WM; Janelle SJ; Dumyati G; Concannon C; Beldavs Z; Cunningham M; Cassidy PM; Phipps EC; Kenslow N; Travis T; Lonsway D; Rasheed JK; Limbago BM; Kallen AJ
JAMA; 2015 Oct; 314(14):1479-87. PubMed ID: 26436831
[TBL] [Abstract][Full Text] [Related]
37. [Clinical characteristics of carbapenem-resistant
Sun Y; Zheng H; Zhang JL; Yu LX; Wang B; Gao W; Cai JZ; Liu YH
Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):640-645. PubMed ID: 32842384
[No Abstract] [Full Text] [Related]
38. Molecular Epidemiology and Risk Factors of Ventilator-Associated Pneumonia Infection Caused by Carbapenem-Resistant Enterobacteriaceae.
Gao B; Li X; Yang F; Chen W; Zhao Y; Bai G; Zhang Z
Front Pharmacol; 2019; 10():262. PubMed ID: 30967778
[TBL] [Abstract][Full Text] [Related]
39. Bacteremia due to carbapenem-resistant Enterobacteriaceae in neutropenic patients with hematologic malignancies.
Satlin MJ; Cohen N; Ma KC; Gedrimaite Z; Soave R; Askin G; Chen L; Kreiswirth BN; Walsh TJ; Seo SK
J Infect; 2016 Oct; 73(4):336-45. PubMed ID: 27404978
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic options for carbapenem-resistant Enterobacteriaceae infections.
Trecarichi EM; Tumbarello M
Virulence; 2017 May; 8(4):470-484. PubMed ID: 28276996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
